Literature DB >> 22817133

Accidental and experimentally induced 5-fluorouracil toxicity in dogs.

Rebecca S Sayre1, James W Barr, E Murl Bailey.   

Abstract

OBJECTIVE: To summarize the literature involving 5-fluorouracil (5-FU) toxicosis in dogs. ETIOLOGY: 5-Fluorouracil's mechanism of action revolves around the metabolism of 5-FU into fluorouridine triphosphate which then interferes with RNA synthesis and function as well as the inhibition of thymidylate synthase which ultimately impairs DNA stability. Toxicity of 5-FU is the most pronounced on rapidly dividing cells. Toxicity manifests itself mainly in the neurologic, gastrointestinal, respiratory, or hematopoietic systems. DIAGNOSIS: History of accidental exposure to 5-FU-containing products. THERAPY: Therapy for 5-FU toxicosis involves typical decontamination procedures and symptomatic therapy for the subsequent toxicity. Seizure control and treatment of the severe gastrointestinal signs that follow are the primary goals in the acute setting. As the disease progresses, management of the sequelae to bone marrow suppression and pulmonary complications are essential. PROGNOSIS: The prognosis for dogs with ingestion of 5-FU is dependent on the amount consumed, with severe intoxication carrying a poor prognosis. Toxic doses can be as little as 5 mg/kg, and doses ≥40 mg/kg are reported to be uniformly fatal. © Veterinary Emergency and Critical Care Society 2012.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22817133     DOI: 10.1111/j.1476-4431.2012.00783.x

Source DB:  PubMed          Journal:  J Vet Emerg Crit Care (San Antonio)        ISSN: 1476-4431


  2 in total

1.  Management of fluorouracil toxicity in a Labrador retriever-poodle crossbred dog.

Authors:  Heather Ellis
Journal:  Can Vet J       Date:  2022-01       Impact factor: 1.008

2.  Toxicity, outcome, and management of anthracycline overdoses in 16 dogs.

Authors:  Haylie C Lawson; Margaret L Musser; Rebecca Regan; Antony S Moore; Ann Hohenhaus; Brian Flesner; Chad M Johannes
Journal:  J Vet Intern Med       Date:  2021-11-25       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.